Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackstone Loan Regulatory News (BGLF)

Share Price Information for Blackstone Loan (BGLF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.57
Bid: 0.55
Ask: 0.59
Change: 0.00 (0.00%)
Spread: 0.04 (7.273%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.57
BGLF Live PriceLast checked at -
Blackstone/GSO Loan Financing is an Investment Trust

To provide shareholders with stable and growing income returns, and to grow the capital value of the investment portfolio by exposure to all debt tranches of CLOs (CLO Income Notes and other CLO Securities) and in Loan Warehouses.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

8 Jan 2019 16:00

RNS Number : 5450M
Blackstone / GSO Loan Financing Ltd
08 January 2019
 

8 January 2019

 

Blackstone / GSO Loan Financing Limited (the "Company")

 

Appointment of a New Non-Executive Director

 

The Company is pleased to announce that Mr Mark Moffat has been appointed as a non-executive director with effect from 8 January 2019.

 

Mark has been involved in the structuring, managing and investing in CLOs for over 20 years. Mark resigned from GSO Capital Partners LP ("GSO"), part of the credit businesses of The Blackstone Group L.P. and an affiliate of the Company's Portfolio Adviser, in early 2015 to pursue other interests.

 

Whilst at GSO, Mark was a Senior Managing Director, Co-Head of the European activities of GSO's Customized Credit Strategies division, and the portfolio manager responsible for funds investing in structured credit, including Carador Income Fund PLC (LSE: CIFU LN). Mark joined GSO in January 2012 following GSO's acquisition of Harbourmaster Capital Management Limited, where he was co-head. Prior to joining Harbourmaster in 2007, Mark was a Senior Managing Director at Bear Stearns, Head of European Debt and Equity Capital Markets and Head of the European CDO business. Whilst at Bear Stearns, Mark led the successful development of the European CDO business over a seven-year period, during which the business was a leader in the securitisation of leveraged loans, asset backed securities, and credit default swaps in Europe. He also sat on the leveraged loan and asset backed securities warehouse committees at Bear Stearns. Prior to Bear Stearns, Mark held similar roles at ABN AMRO where he was global head of CLOs and at Greenwich NatWest, where he was a Director in the Principal Finance Team.

 

The Board does not consider Mark to be an independent director due to his recent employment with GSO. However, the Board believes that his knowledge and experience will be a valuable addition to the Board.

 

There are no matters in respect of Mr Moffat requiring disclosure under paragraphs 9.6.13 (1) to (6) of the Listing Rules.

 

Contacts:

 

BNP Paribas

Melissa Le Cheminant/Siobhan Lavery 01534 813873 / 709181

 

Fidante Capital

John Armstrong-Denby/Nick Donovan 020 7832 0900

 

N+1 Singer Advisory LLP

David Floyd/James Maxwell 07785 938 065 / 02074 963056

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGUPAGUPBGAR
Date   Source Headline
21st Nov 20224:41 pmRNSTransaction in Own Shares
21st Nov 20227:00 amRNSNet Asset Value(s) and Monthly Report
18th Nov 20224:59 pmRNSTransaction in Own Shares
17th Nov 20224:32 pmRNSTransaction in Own Shares
16th Nov 20224:42 pmRNSTransaction in Own Shares
15th Nov 20224:49 pmRNSTransaction in Own Shares
15th Nov 202210:22 amRNSQ3 2022 Report and Investor Call
14th Nov 20224:59 pmRNSTransaction in Own Shares
11th Nov 20224:44 pmRNSTransaction in Own Shares
10th Nov 20224:28 pmRNSTransaction in Own Shares
9th Nov 20224:40 pmRNSTransaction in Own Shares
8th Nov 20224:43 pmRNSTransaction in Own Shares
7th Nov 20225:06 pmRNSTransaction in Own Shares
4th Nov 20224:51 pmRNSTransaction in Own Shares
3rd Nov 20224:39 pmRNSTransaction in Own Shares
2nd Nov 20224:46 pmRNSTransaction in Own Shares
1st Nov 20225:10 pmRNSTransaction in Own Shares
1st Nov 20223:28 pmRNSTotal Voting Rights
31st Oct 20222:59 pmRNSTransaction in Own Shares
28th Oct 20225:20 pmRNSTransaction in Own Shares
27th Oct 20225:23 pmRNSTransaction in Own Shares
26th Oct 20225:23 pmRNSTransaction in Own Shares
25th Oct 20225:27 pmRNSTransaction in Own Shares
24th Oct 20225:28 pmRNSTransaction in Own Shares
21st Oct 20223:39 pmRNSShare Repurchase Programme
21st Oct 20227:00 amRNSNet Asset Value, Monthly Report and Investor Call
21st Oct 20227:00 amRNSDividend Declaration
19th Oct 20225:02 pmRNSTransaction in Own Shares
18th Oct 20225:07 pmRNSTransaction in Own Shares
14th Oct 20224:50 pmRNSTransaction in Own Shares
13th Oct 20222:11 pmRNSTransaction in Own Shares
12th Oct 20224:46 pmRNSTransaction in Own Shares
11th Oct 20225:18 pmRNSTransaction in Own Shares
6th Oct 20225:31 pmRNSTransaction in Own Shares
3rd Oct 20223:44 pmRNSTotal Voting Rights
30th Sep 20223:33 pmRNSTransaction in Own Shares
29th Sep 20224:49 pmRNSTransaction in Own Shares
29th Sep 20229:45 amRNSDirector Declaration
28th Sep 20223:37 pmRNSTransaction in Own Shares
27th Sep 20225:26 pmRNSTransaction in Own Shares
26th Sep 20225:15 pmRNSTransaction in Own Shares
23rd Sep 20224:45 pmRNSTransaction in Own Shares
22nd Sep 20225:15 pmRNSTransaction in Own Shares
22nd Sep 20225:15 pmRNSHalf Year Report
22nd Sep 20227:00 amRNSNet Asset Value(s)
21st Sep 20225:25 pmRNSTransaction in Own Shares
20th Sep 20225:14 pmRNSTransaction in Own Shares
15th Sep 20224:47 pmRNSTransaction in Own Shares
14th Sep 20224:24 pmRNSTransaction in Own Shares
13th Sep 20224:48 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.